COVID-19 Impact and Recovery Analysis | Pharmaceutical Excipients Market Procurement Intelligence Report Forecasts Spend Growth of over USD 3 billion
The Pharmaceutical Excipients Market is poised to experience spend growth of more than USD 3 billion between 2020-2024 at a CAGR of over 7.39%. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Request free sample pages
Read the 120-page research report with TOC and LOE on "Pharmaceutical Excipients Market ? Procurement Intelligence Report, Pricing Outlook in Geographies that include APAC, North America, South America, and MEA, and insights into best practices to optimize procurement spend."
SpendEdge's reports now include an in-depth complimentary analysis of the COVID-19 impact on procurement and the latest market data to help your company overcome sourcing challenges. Our Pharmaceutical Excipients Market procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights into the best procurement practices to mitigate losses.
Suppliers in this market have moderate bargaining power owing to moderate pressure from substitutes and a moderate level of threat from new entrants.
Buyers can benchmark their preferred pricing models for pharmaceutical excipients Market, Procurement, Management with the wider industry information and identify the cost-saving potential.
Insights to help buyers identify and shortlist the most suitable suppliers for their Pharmaceutical Excipients Market requirements. This procurement report answers the following questions:
Am I engaging with the right suppliers?
Which KPIs should I use to evaluate my incumbent suppliers?
Which supplier selection criteria are relevant for?
What are the Pharmaceutical Excipients Market category essentials in terms of SLAs and RFx?
To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment, Subscribe Now for Free.
Insights into strategies that will help buyers optimize their category management practices. The report answers the following questions:
What should be my strategic procurement objectives, activities, and enablers for the Pharmaceutical Excipients Market category?
What negotiation levers can I pull for cost-saving?
What are Pharmaceutical Excipients Market procurement best practices I should be promoting in my supply chain?
Some of the top Pharmaceutical Excipients Market suppliers enlisted in this report
This Pharmaceutical Excipients Market procurement intelligence report has enlisted the top suppliers and their cost structures, SLA terms, best selection criteria, and negotiation strategies.
Evonik Industries AG
BASF SE
Archer-Daniels-Midland Co.
Ashland Global Specialty Chemicals Inc.
Roquette Frères SA
L'Air Liquide SA
Croda International Plc
Berkshire Hathaway Inc.
Wittington Investments Ltd.
Asahi Kasei Corp.
Get access to regular sourcing and procurement insights to our digital procurement platform- Contact Us.
Table of Content
Executive Summary
Market Insights
Category Pricing Insights
Cost-saving Opportunities
Best Practices
Category Ecosystem
Category Management Strategy
Category Management Enablers
Suppliers Selection
Suppliers under Coverage
US Market Insights
Category scope
Appendix
About SpendEdge:
SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know morehttps://www.spendedge.com/request-for-demo
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to ResearchAndMarkets.com's offering.
Infectious disease Dx is...
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
Will all...
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...